Skip to content

Clinical and immunological profiles of antinuclear antibody positivity in chronic spontaneous urticaria: a case-control study

Aug 2026 · Archives of Dermatological Research · Vol 318 · 0 citations · 21 references

TL;DR

Higher ANA titers and the DFS pattern identify subgroups with enhanced autoantibody reactivity and distinct inflammatory characteristics in patients with CSU and support the immunologic heterogeneity of CSU.

View source

Similar papers

Open access Aug 2026

Antinuclear antibody positivity rate and clinical characteristics in prurigo chronica multiformis: a retrospective study of 26 patients

It is suggested that prurigo chronica multiformis may include an immunologic subtype in which autoimmunity and allergic inflammation intersect, and ANA-positive patients showed a high rate of allergen sensitization and a lower peripheral blood eosinophil percentage.

Kyoko Muraoka, Yutaka Inaba, K. Kayama et al. · 0 citations
Aug 2026

Anti-centromere antibody positivity: a spectrum of clinical diagnoses and immunological patterns in a large patient cohort

Primary biliary cholangitis and Sjögren’s syndrome, not systemic sclerosis, are the most common definitive autoimmune diseases in the large anti-CENP-B-positive patient cohort, supporting their complementary role in clinical phenotyping and diagnostic evaluation.

Ya-Dan Li, Guang-Zhi Xiao, Rong-Rong Dou et al. · 0 citations
Open access Aug 2026

Coexistence of Allergy and Antinuclear Antibody in Early Childhood

Background: Allergy and autoantibody production are two abnormal conditions of the immune system, resulting from hypersensitivity. It remains unclear whether autoantibodies are also present in association with allergies that begin during early childhood. This study aims to evaluate the presence of antinuclear antibodie...

Faruk Dişli, Y. Yilmaz, Ercan Yılmaz et al. · 0 citations
Review Open access Sep 2026

Prevalence and associated factors of secondary hypogammaglobulinemia following rituximab therapy in a real-world cohort

Rituximab, an anti-CD20 monoclonal antibody, is widely used in the treatment of autoimmune and hematological diseases. However, its use has been associated with secondary hypogammaglobulinemia (SHG), a condition that may increase susceptibility to infections. The prevalence and clinical factors associated with SHG rema...

J. Ruíz-Santana, Oscar Aquino-Arango, Fernando Lozano-Patiño et al. · 0 citations
Open access Sep 2026

Frequency and clinical impact of parvovirus B19 in systemic lupus erythematosus patients at Zagazig University Hospital

Systemic Lupus Erythematosus (SLE) is a chronic multisystem autoimmune disease whose complex etiology involves an interplay between hormonal, genetic and environmental factors. Viral infections, particularly Parvovirus B19 (B19V), are recognized as potential contributors to autoimmune pathogenesis and can induce transi...

Dina M. Atef, Wafaa K. Makram, H. Kadry et al. · 0 citations
Review Jun 2026

Prognostic Outcomes in Seropositive and Seronegative Autoimmune Encephalitis

Objectives: Autoimmune Encephalitis (AE) is an immune-mediated inflammatory disorder of the central nervous system with heterogeneous clinical manifestations and variable outcomes. The prognostic significance of antibody status (seropositive vs. seronegative) remains incompletely understood, particularly in Iranian pop...

Mohammad Vafaee-Shahi, Azita Tavasoli, Maryam Kachuei et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.